"Despite current world economic uncertainty, Senetek is in a secure and strong position to execute on its sales, marketing and development strategy," says Mr. Massino. "Senetek's strength will continue to be the development and commercialization of patentable products with treatment advantages."
About Senetek, PLC
Senetek PLC (OTCBB: SNKTY) is a life sciences company engaged in the development of technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.
This news release contains statements that may be considered 'forward-
looking statements' within the meaning of the Private Securities Litigation
Reform Act. Forward-looking statements by their nature involve substantial
uncertainty, and actual results may differ materially from those that might
be suggested by such statements. Important factors identified by the
Company that it believes could result in such material differences are
described in the Company's Annual Report on Form 10-K for the year 20
|SOURCE Senetek PLC|
Copyright©2008 PR Newswire.
All rights reserved